Middle east and asia injectable drugs market
Middle East and Asia Injectable Drugs Market, by Product Type (Pre-filled Syringes, Auto-injectors, Pre-filled Pens, Pre-mixed IV Bags, and Others), by Drug Class (Anesthesia, Antibiotics, Antidotes, Antiemetic, Anti-infective, Anti-thrombolytic, Muscle Relaxant, Non Opioids, Opioids, Sedatives, and Others), by Route of Administration (Intramuscular (IM), Intravenous (IV), Subcutaneous (SC), and Others (Epidural and Intrathecal)), and by End Users (Hospitals, Clinics, and Ambulatory Surgery Centers) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
- Aug 2023
- CMI4891
- 90 Pages
- Excel & Pdf
- Medical Devices
To achieve a therapeutic effect in humans and animals, drug delivery is the method of delivering a pharmaceutical compound. Nasal and pulmonary routes are gaining increasing importance of drug delivery for the treatment on humans. For peptide and protein therapeutics these routes of drug delivery provide promising alternative to parenteral drug delivery.
The use of injectable drug delivery with advent of self-injection devices such as auto-injectors, pen-injectors, has made administration of drugs easy for patients at home without any medical assistance.
Figure 1. Middle East and Asia Injectable Drugs Market Value (US$ Mn), By Product Type, 2021
Figure 1.1 Middle East and Asia Injectable Drugs Market Value (US$ Mn), By Product Type, 2028
Middle East and Asia Injectable Drugs Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2020 | Market Size in 2021: | US$ 4,15,000 Mn |
| Historical Data for: | 2017 to 2020 | Forecast Period: | 2021 to 2028 |
| Forecast Period 2021 to 2028 CAGR: | 8.2% | 2028 Value Projection: | US$ 7,23,164 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Kalbe Farma, Takeda pharmaceuticals Co. Ltd., Livzon Pharmaceutical Group, Inc., Sun Pharmaceutical Industries, Ltd., Pfizer, Inc., Sanofi, Novartis, Tabuk, Novo Nordisk, GlaxoSmithKline plc, AstraZeneca, and Gerresheimer AG |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Figure 2. Middle East and Asia Injectable Drugs Market Value (US$ Mn), By Route of Administration, 2021
Figure 2.1. Middle East and Asia Injectable Drugs Market Value (US$ Mn), By Route of Administration, 2028
Middle East and Asia Injectable Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 3.3 million new cases were reported, across the globe.
The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. Likewise, COVID-19 pandemic is expected to have a negative impact on Middle East and Asia injectable drugs market
Even if the COVID-19 pandemic has caused a huge disruption in global pharmaceutical supply chain, in Saudi COVID-19 impact was largely manageable in healthcare institutions. There are various reasons that can attribute between the effective exchange programs within the hospitals and huge increase in public healthcare such as technological advancements, ageing populations, changing disease patterns.
Middle East and Asia Injectable Drugs Market - Restraint
In Middle East, the diseases which are non-communicable are causing premature deaths such as heart disease (45%) and stroke (36%). The growing burden of non-communicable diseases in the region is increasing because of improper diet, smoking, high B.P., and huge body mass.
The market forces are to be taken over because of government failure to provide comprehensive healthcare services. So this has changed it in a commodity with curative impact rather than just preventive. The development of health systems had been driven by economic opportunities for providers.
Key Players
Major players operating in the Middle East and Asia Injectable Drugs Market include Kalbe Farma, Takeda pharmaceuticals Co. Ltd., Livzon Pharmaceutical Group, Inc., Sun Pharmaceutical Industries, Ltd., Pfizer, Inc., Sanofi, Novartis, Tabuk, Novo Nordisk, GlaxoSmithKline plc, AstraZeneca, and Gerresheimer AG
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By End Users
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Product approval and launches
- Merges and Acquisitions
- Key development
- Middle East and Asia drug approval process
- Regulatory Scenario
- Reimbursement Scenario
- Brand Analysis
- PEST Analysis
- Pricing Analysis
- Technology Advancement
- Market Dynamics
- Middle East and Asia Injectable Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Middle East and Asia Injectable Drugs Market, By Product Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Pre-filled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Vaccines
- Blood Stimulants
- Biologics
- Others
- Auto-injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Pre-filled Pens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Pre-mixed IV Bags
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Sedative Products (Sedation)
- Anesthesia Products (Anesthesia)
- Pain Management Products (Post-operative analgesic pain management)
- Chemotherapy Products (Chemotherapy)
- Antibacterial Products (Infectious diseases)
- Electrolyte and Nutrition Products (Electrolyte and Nutrition)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Middle East and Asia Injectable Drugs Market, By Route of Administration, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Intramuscular (IM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Subcutaneous (SC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others (Epidural and Intrathecal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Middle East and Asia Injectable Drugs Market, By Drug Class , 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Anesthesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Antidotes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Antiemetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Anti-thrombolytic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Muscle Relaxant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Non Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Sedatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Middle East and Asia Injectable Drugs Market, By End Users, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Middle East and Asia Injectable Drugs Market, By Country, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018–2028
- Country Trends
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2017 – 2028, (US$ Mn)
- Asia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-Users, 2017 – 2028, (US$ Mn)
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Kalbe Farma
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Pfizer Inc.
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Novo Nordisk A/S
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Takeda Pharmaceutical Co. Ltd.
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Livzon Pharmaceutical Group, Inc.
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Sun Pharmaceutical Industries, Ltd.
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Sanofi
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Novartis
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Tabuk
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- GlaxoSmithKline plc
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- AstraZeneca
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Gerresheimer AG
- Company highlights
- Product Portfolio
- Key Highlights
- Financial performance
- Strategies
- Kalbe Farma
- Section
- References
- Research Methodology
- About Us and Sales Contact
*Browse 30 market data tables and 35 figures on "Middle East and Asia Injectable Drugs Market” - forecast to 2028
Detailed Segmentation:
- Middle East and Asia Injectable Drugs Market, By Product Type:
- Pre-filled Syringes
- Vaccines
- Blood Stimulants
- Biologics
- Others
- Auto-injectors
- Pre-filled Pens
- Pre-mixed IV Bags
- Sedative Products (Sedation)
- Anesthesia Products (Anesthesia)
- Pain Management Products (Post-operative analgesic pain management)
- Chemotherapy Products (Chemotherapy)
- Antibacterial Products (Infectious diseases)
- Electrolyte and Nutrition Products (Electrolyte and Nutrition)
- Others
- Pre-filled Syringes
- Middle East and Asia Injectable Drugs Market, By Route of Administration:
- Intramuscular (IM)
- Intravenous (IV)
- Subcutaneous (SC)
- Others (Epidural and Intrathecal)
- Middle East and Asia Injectable Drugs Market, By Drug Class:
- Anesthesia
- Antibiotics
- Antidotes
- Antiemetic
- Anti-infective
- Anti-thrombolytic
- Muscle Relaxant
- Non Opioids
- Opioids
- Sedatives
- Others
- Middle East and Asia Injectable Drugs Market, By End Users:
- Hospitals
- Clinics
- Ambulatory Surgery Centers